Navigation Links
ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
Date:6/7/2011

SAN ANTONIO, June 7, 2011 /PRNewswire/ -- ImaginAb, Inc. is pleased to announce the availability of custom radiolabeling services for proteins, peptides and other macromolecules as of the 1st of July 2011. This is part of the company's ongoing initiative to broaden the range of product and service offerings to the biopharma and research community and is synergistic with existing activities in custom antibody fragment engineering.

"Over the past 18 months we have grown our core antibody engineering program to over a dozen 'companion diagnostic' programs with pharmaceutical companies in addition to our own internal pipeline" commented Jenny Keppler, President and COO of ImaginAb. "In response to very high demand for our radiochemistry and, in particular our antibody labeling expertise, we have decided to make this capability a standard service offering as part of our recent LA facility expansion."

Protein/peptide labeling services will initially focus on F-18, Cu-64, I-124. Please contact sales@imaginab.com for further information and pricing.

About ImaginAb

Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products. For more information about ImaginAb, visit www.imaginab.com.

*the technologies described in this press release are available for pre-clinical / non-human use only.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Anna Wu

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91513


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems
2. ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia
3. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
4. Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA
5. Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
6. Thoratec Announces Presentations at Upcoming Investor Conferences
7. COPAN Announces Strategic Global Distribution Partnership with Siemens
8. Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations
9. PDL BioPharma Announces Conversion Rate Adjustments for its Convertible Notes
10. Shenzhen Wuzhou Changlian International Trading Co. Announces Arrival of New Infrared Thermometer Series
11. Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... New York , May 31, 2016 ... an essential ingredient in food, cosmetics and pharmaceuticals, with ... representing revenues worth US$ 1.6 Bn. Demand ... cosmetics products, juices, and yogurts will continue its upward ... wellness trend will also boost positive sentiment on aloe ...
(Date:5/31/2016)... ZIONA, Israel , May 31, 2016 ... company utilizing its proprietary plant-based rhCollagen technology for tissue ... from the Chief Scientist of Israel,s ... its NIS 12 million development project for 2016. The Chief ... than last year,s authorized grant, which totaled NIS 4.7 ...
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... Sunny Isles Beach is in the ... flooding, or loss of utility services. The time for planning is now, before a ... have a plan in place. Families should follow the recommendations of the Miami-Dade County ...
(Date:5/31/2016)... , ... May 31, 2016 , ... According to recent ... States, and more than 100,000 physical therapy clinics. Each physical therapy professional and ... of clients. At the same time, staying afloat in a competitive industry is also ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... Pardoe, FDAI, DAHC, CDC, has joined the Fire Door Solutions’ team. Keith ... and fire door and frame in-field re-labeling. He will be instrumental in ...
(Date:5/31/2016)... ... ... More than 80 representatives of the Hepatitis B Foundation , Hepatitis C ... event on National Hepatitis Testing Day outside of Philadelphia City Hall to raise awareness ... liver cancer. , Foundation leaders and the citywide coalition they created, Hep B United ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. Joseph Medical Center ... information exchange, which enables physicians at SJMC’s two hospital campuses, downtown and in ... organizations in the exchange. SJMC’s membership in the health information exchange underscores the ...
Breaking Medicine News(10 mins):